SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vol who wrote (2340)11/12/1997 5:53:00 PM
From: Rubble   of 23519
 
Volunteer- I finally got around to reading the Newsweek article, and while I found it blatantly pro-Viagra, I don't consider it anti-VVUS. To people who don't grasp all the medical implications of systemic v local applications, a pill sounds a hundred times better than MUSE and a million times better than Caverject. That's just the way things are, and I'd give the public some time to digest all the new info that will be coming out in the ED field before I'd start assessing VVUS' place in the future of ED treatment. Any pill touted as the panacea of erectile dysfunction is doomed to disappoint a whole lot of users...and investors.

< Some hapless 30 year-old is permanently impotent and was lucky to have survived after using a medieval torture therapy, otherwise known as MUSE. >

As for this statement, which led me to believe there was libelous material about VVUS in Newsweek, I found no such implication in the article. While a picture of MUSE was shown just below the section that caused your confusion, the article implied it was a needle treatment that caused "Bill" to become impotent: "he had never had any problems in the sack. But he was tempted by a friend's injection medication."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext